Plunkett Research Online: Immunotech Laboratories Inc

IMMUNOTECH LABORATORIES INC (IMMB:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Immunotech Laboratories, Inc. is an organization with full indefinite licensing rights of the Irreversible Pepsin Fraction peptide molecule for the specific treatment and preventing of the HIV/AIDS indication......



Immunotech Laboratories Inc
Ticker: IMMB
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 818 409-9091
Fax:
Address: 116 W. Stocker Street
Glendale, CA 91202 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription

Immunotech Laboratories, Inc. is an organization with full indefinite licensing rights of the Irreversible Pepsin Fraction peptide molecule for the specific treatment and preventing of the HIV/AIDS indication......See More See More

Auditor: Jay J. Shapiro, C.P.A.
Legal Advisor: Law Offices of Joseph L. Pittera
$USD, In whole numbers,
except marked * or %
2009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: